A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
NCT04834778
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Cell Carcinoma
Gastric Cancer
Metastatic Breast Cancer
Small-cell Lung Cancer
Other Solid Tumors
Interventions
DRUG:
HC-5404-FU
Sponsor
HiberCell, Inc.
Collaborators
[object Object]